Search


ASGCT 2026: SonoThera has a unique ultrasound-mediated nonviral approach to gene therapy. It has plans to be in the clinic for DMD next year
Co-Founder & CEO Ken Greenberg describes the idea around and advantages of this approach, including no limitation on cargo size. He describes how it would work for DMD, and what other conditions and uses they are thinking of next. Coverage brought to you by
8 hours ago






.png)
